Lung cancer screening: latest developments and unanswered questions.
about
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.Controlled settings for lung cancer screening: why do they matter? Considerations for referring clinicians.Mutational analysis of mitochondrial tRNA genes in patients with lung cancer.Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers.Selecting high-risk individuals for lung cancer screening; the use of risk prediction models vs. simplified eligibility criteria.
P2860
Lung cancer screening: latest developments and unanswered questions.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Lung cancer screening: latest developments and unanswered questions.
@en
type
label
Lung cancer screening: latest developments and unanswered questions.
@en
prefLabel
Lung cancer screening: latest developments and unanswered questions.
@en
P1476
Lung cancer screening: latest developments and unanswered questions
@en
P2093
Carlijn M van der Aalst
Harry J de Koning
P304
P356
10.1016/S2213-2600(16)30200-4
P577
2016-09-01T00:00:00Z